An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
STAAR Surgical to Participate in Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
STAAR Surgical Company announced its participation in several upcoming investor conferences.
Positive
STAAR management will participate in the Canaccord Genuity Annual Growth Conference on August 9, the Needham Virtual MedTech & Diagnostics Conference on August 15, the Piper Sandler West Coast Field Trip on August 23, the William Blair West Coast Field Trip on August 30, and the Goldman Sachs European Medtech and Healthcare Services Conference on September 6.
Negative
None.
LAKE FOREST, Calif.--(BUSINESS WIRE)--
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye,today announced that management will participate in several upcoming investor conferences.
STAAR management will participate in the following investor conferences:
Canaccord Genuity Annual Growth Conference, Wednesday, August 9. Management Presentation and Q&A at 10:00 a.m. Eastern / 7:00 a.m. Pacific at the following link: https://wsw.com/webcast/canaccord89/staa/2452967
Needham Virtual MedTech & Diagnostics Conference, Tuesday, August 15
Piper Sandler West Coast Field Trip, Wednesday, August 23
William Blair West Coast Field Trip, Wednesday, August 30
Goldman Sachs European Medtech and Healthcare Services Conference, September 6
In-person attendance at the investor conferences is by invitation only from each sponsoring brokerage firm. Please contact each brokerage firm directly for more information.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”, which includes the EVO ICL™ product line. More than 2,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.
Investors & Media
Brian Moore
Vice President, Investor, Media Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com
Source: STAAR Surgical Company
FAQ
Which investor conferences will STAAR Surgical Company participate in?
STAAR Surgical Company will participate in the Canaccord Genuity Annual Growth Conference, the Needham Virtual MedTech & Diagnostics Conference, the Piper Sandler West Coast Field Trip, the William Blair West Coast Field Trip, and the Goldman Sachs European Medtech and Healthcare Services Conference.
When will the Canaccord Genuity Annual Growth Conference take place?
The Canaccord Genuity Annual Growth Conference will take place on August 9.
How can I attend the investor conferences?
In-person attendance at the investor conferences is by invitation only from each sponsoring brokerage firm. Please contact each brokerage firm directly for more information.
staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl". nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad